u/hamza_weiss

Strongly agree. A1c matters as much as weight.

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

state the method: column, gradient, detection wavelength, injection volume

A shoulder on the main peak that 6 analysts integrated 15 different ways.

Yes, exactly this, and it is the bit that took me 14 weeks to accept.

pentadecapeptide is sequence, the supply chain naming is a mess

metformin combo is standard

copay is separate from coverage

customs clearance often breaks the cold chain, factor that in

Stalled at 0.25mg, changed nothing, and it started moving again on week 25. Very nearly went up. Glad I did not.

Strongly agree. If it is not working at 0.25mg after 72 weeks, going up is not automatically the answer.

pentadecapeptide is sequence, the supply chain naming is a mess

sequence and naming claims need the actual sequence

Stalled for 10 weeks, changed nothing, and it started moving again on week 71.

Do you have an import allowance in your jurisdiction?

Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.

Disagree. What you are describing is consistent with SURPASS, not with what you concluded.

sponsor and disclosure questions are always answered publicly

lyophilised powder is far more forgiving than reconstituted solution

the logger trace is the data that matters, not the packaging promises

Crossposting this to c/vendorvetting because the people who need it are not reading this community.